Motley Fool Australia

Polynovo Ltd (ASX: PNV) Share Price and News

Price
Movement
52 Week Range
-
1 Year Return
(20 mins delayed)

() Chart and Price Data

.

Share Price
Previous Close
Volume
Day Change
Open
Monthly Average Volume
52 Week Range -
Days Range -
Turnover

Polynovo Ltd (ASX: PNV) Latest News

ASX 200

ASX 200 rises 0.4%

More »

ASX 200 up 0.5%: BHP’s update, PolyNovo jumps, Ansell impresses

More »

beat the share market

Why Afterpay, Ansell, MyDeal, & PolyNovo shares are storming higher today

More »

A young man pointing up looking amazed, indicating a surging share price movement for an ASX company

Why the PolyNovo (ASX:PNV) share price is zooming 7% higher today

More »

Wooden block letters spelling 'Recap' on a yellow background

ASX 200 Weekly Wrap: ASX drops despite promises of more US stimulus

More »

asx shares falling lower represented by investor wearing paper bag on head with sad face

These were the worst performing ASX 200 shares last week

More »

shares lower

Why Advance Nanotek, Polynovo, Resolute, & Tyro shares are dropping lower

More »

ASX 200 shares

ASX 200 up 0.4%: Afterpay hits record high, bank shares rise, Resolute disappoints

More »

Recent Stock Announcements

Price Sensitive Only$An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
Show All
Date Heading $An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security. Time Pages File Size
 

About Polynovo Ltd (ASX: PNV)

Polynovo Ltd (ASX: PNV) is an Australian-based medical device company that designs, develops and manufactures dermal regeneration solutions.

Its flagship patented NovoSorb biodegradable polymer technology is used to develop innovative medical devices that help surgeons treat patients with traumatic wounds. The company also has a development program covering breast sling, hernia, and orthopaedic applications.

Investors in the Polynovo share price will be happy to know the company is preparing for growth by expanding its manufacturing facility and headquarters in Melbourne, and establishing high quality processes that enable product innovation.

Director Transactions

Data provided by Morningstar.
Date Director Type Amount Value Notes
02 Dec 2020 Leon Hoare Sell 100 $345,400
01 Dec 2020 Bruce Rathie Sell 355 $1,194,478
01 Dec 2020 Paul Brennan Sell 200 $678,000
27 Aug 2020 David Williams Buy 500 $1,020,994
27 May 2020 David McQuillan Sell 441 $1,181,554
30 Mar 2020 David Williams Buy 100 $154,000
23 Mar 2020 David Williams Buy 100 $140,000
17 Mar 2020 David Williams Buy 100 $147,500
10 Mar 2020 David McQuillan Buy 50 $95,000
09 Mar 2020 Robert (Max) Johnston Buy 22 $49,772
09 Mar 2020 David Williams Buy 500 $1,049,500
02 Mar 2020 Bruce Rathie Buy 50 $120,000
27 Feb 2020 David Williams Buy 100 $221,000
27 Feb 2020 David Williams Buy 100 $228,029
27 Feb 2020 David Williams Buy 400 $988,149
Show more


Directors & Management

Data provided by Morningstar.
Name Title StartDate Profile
Mr David Williams Non-Executive Director,Non-Executive Chairman Feb 2014
Mr Bruce Rathie Non-Executive Director Feb 2010
Mr Paul Brennan Managing Director Feb 2015
Dr Robyn Elliott Non-Executive Director Oct 2019
Dr David McQuillan Non-Executive Director Aug 2012
Mr Leon Hoare Non-Executive Director Jan 2016
Ms Christine Emmanuel Non-Executive Director May 2020
Mr Jan-Marcel Gielen Chief Financial Officer,Company Secretary Dec 2018
Jan-Marcel Gielen Chief Financial Officer,Company Secretary
Show more

Top Share Holders

Data provided by Morningstar.
Name Shares Capital
Hsbc Custody Nominees (Australia) Limited 66,551,382 10.07%
J P Morgan Nominees Australia Pty Limited 50,570,980 7.65%
Citicorp Nominees Pty Limited 19,619,513 2.97%
Moggs Creek Pty Ltd 17,400,000 2.63%
Lateral Innovations Pty Ltd 10,924,103 1.65%
National Nominees Limited 9,834,664 1.49%
Merrill Lynch (Australia) Nominees Pty Limited 9,308,685 1.41%
Mr Anthony Shane Kittel & Mrs Michele Therese Kittel 7,922,500 1.20%
BNP Paribas Nominees Pty Ltd 6,625,645 1.00%
BNP Paribas Nominees Pty Ltd (I) 6,186,654 0.94%
Sandhurst Trustees Ltd 5,688,623 0.86%
BNP Paribas Noms Pty Ltd 5,375,513 0.81%
Mr Paul Gerard Brennan 4,185,095 0.63%
Ms Simone Maree Beks 4,185,095 0.63%
Commonwealth Scientific And Industrial Research Organisation 4,081,250 0.62%
Netwealth Investments Limited 3,809,451 0.58%
Mr Paul James Lappin & Ms Siobhan Catherine Lyons 3,254,631 0.49%
Mr Laurent Fossaert 3,214,172 0.49%
Mr David Kenley 3,139,855 0.47%
Dr Marcus James Dermot Wagstaff & Mrs Lara Kate Wagstaff 3,056,377 0.46%
Show more